Device Trial Radar · NCT02408458
Miromatrix Biological Mesh for Ventral Hernia Repair
Last checked: Nov 19, 2026Latest source record: Oct 3, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jun 2015
Primary completion
Apr 2016
Study completion Apr 2016
Sponsor
- Lead sponsor
- Miromatrix Medical Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 3, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being conducted to gather long-term data of the performance of the Miromatrix Biological Mesh.
Conditions
- Ventral Hernia
Interventions
MIROMESH®Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hernia recurrence requiring surgical interventionTime frame: 1 year
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Sarasota Memorial Hospital
Sarasota, Florida
University of Kentucky
Lexington, Kentucky
Penn State Hershey Medical Center
Hershey, Pennsylvania
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.